COMMUNIQUÉ DE PRESSE publié le 05/08/2024 à 15:45, il y a 1 année 8 mois Eckert & Ziegler extends GalliaPharm® availability to the entire European Economic Area Eckert & Ziegler SE extends availability of GalliaPharm® to the entire European Economic Area after receiving EC approval, offering cost-effective radiolabeling solution for PET diagnostics Eckert & Ziegler SE European Economic Area GalliaPharm® EC Approval Radiolabeling
COMMUNIQUÉ DE PRESSE publié le 05/08/2024 à 15:43, il y a 1 année 8 mois Form 8.3 - The Vanguard Group, Inc.: International Paper Company The Vanguard Group, Inc. discloses 11.74% stake in International Paper Company as of 02 August 2024 The Vanguard Group, Inc. Disclosure Stake International Paper Company Stock
COMMUNIQUÉ DE PRESSE publié le 05/08/2024 à 15:42, il y a 1 année 8 mois Form 8.3 - The Vanguard Group, Inc.: Balanced Commercial Property Trust Limited The Vanguard Group, Inc. discloses a 4.35% ownership in Balanced Commercial Property Trust Limited in a Form 8.3 filing The Vanguard Group, Inc. Form 8.3 Financial Filing Ownership Disclosure Balanced Commercial Property Trust Limited
COMMUNIQUÉ DE PRESSE publié le 05/08/2024 à 15:41, il y a 1 année 8 mois Form 8.3 - The Vanguard Group, Inc.: Ascential plc The Vanguard Group, Inc. discloses 5.13% stake in Ascential plc. Details on securities holdings, derivatives, and recent dealings provided in Form 8.3 Form 8.3 The Vanguard Group Dealings Securities Holdings Ascential Plc
COMMUNIQUÉ DE PRESSE publié le 05/08/2024 à 15:40, il y a 1 année 8 mois Form 8.3 - The Vanguard Group, Inc.: Darktrace plc The Vanguard Group, Inc. discloses a 2.83% stake in Darktrace plc on 02 August 2024. Details in Form 8.3 under the Takeover Code Form 8.3 Takeover Code Vanguard Group Stake Disclosure Darktrace Plc
COMMUNIQUÉ DE PRESSE publié le 05/08/2024 à 15:40, il y a 1 année 8 mois Form 8.3 - The Vanguard Group, Inc.: Network International Holdings plc The Vanguard Group, Inc. discloses a 4.72% stake in Network International Holdings plc per Form 8.3 filing on 02 August 2024 Form 8.3 Vanguard Group Financial Disclosure Stake Disclosure Network International Holdings
COMMUNIQUÉ DE PRESSE publié le 05/08/2024 à 15:39, il y a 1 année 8 mois Form 8.3 - The Vanguard Group, Inc.: Redrow plc The Vanguard Group, Inc. discloses 4.27% stake in Redrow plc as of 02 August 2024. Dealings include sale of 755 securities at 7.44 GBP per unit Securities Vanguard Group Redrow Plc Dealings Stake
COMMUNIQUÉ DE PRESSE publié le 05/08/2024 à 15:38, il y a 1 année 8 mois Form 8.3 - The Vanguard Group, Inc.: International Distribution Services plc The Vanguard Group, Inc. disclosed a 3.73% stake in International Distribution Services plc through Form 8.3 on 05-Aug-2024 Form 8.3 Disclosure Vanguard Group Stake International Distribution Services Plc
COMMUNIQUÉ DE PRESSE publié le 05/08/2024 à 15:37, il y a 1 année 8 mois Form 8.3 - The Vanguard Group, Inc.: NewRiver REIT plc The Vanguard Group, Inc. discloses a 1.08% position in NewRiver REIT plc as of 02 August 2024. Details in accordance with Rule 8.3 of the Takeover Code Position Disclosure Rule 8.3 Vanguard Group Financial Securities NewRiver REIT Plc
COMMUNIQUÉ DE PRESSE publié le 05/08/2024 à 15:36, il y a 1 année 8 mois Form 8.3 - The Vanguard Group, Inc.: Virgin Money UK plc The Vanguard Group, Inc. discloses a 5.89% stake in Virgin Money UK plc. Purchase of 10p ordinary shares and CDIs made on 02 August 2024 Vanguard Group Stake Disclosure 10p Ordinary Shares Virgin Money UK Plc CDIs
Publié le 09/04/2026 à 07:00, il y a 8 heures 27 minutes bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing
Publié le 09/04/2026 à 07:00, il y a 8 heures 27 minutes bioMérieux lance sa solution de diagnostic moléculaire BIOFIRE® SPOTFIRE® pour l’industrie pharmaceutique afin de renforcer le dépistage rapide des mycoplasmes
Publié le 08/04/2026 à 18:17, il y a 21 heures 9 minutes Mise à disposition du Rapport sur la solvabilité et la situation financière 2025 du Groupe des Assurances du Crédit Mutuel
Publié le 08/04/2026 à 18:16, il y a 21 heures 10 minutes Mise à disposition des états financiers 2025 du Groupe des Assurances du Crédit Mutuel
Publié le 08/04/2026 à 18:02, il y a 21 heures 25 minutes Publication of the 2025 Universal Registration Document
Publié le 09/04/2026 à 14:40, il y a 47 minutes Silver X Delivers Production Growth During the First Quarter of 2026
Publié le 09/04/2026 à 14:00, il y a 1 heure 27 minutes Orogen Royalties Announces Mineral Reserve and Resource Update on Producing Ermitaño Royalty
Publié le 09/04/2026 à 13:30, il y a 1 heure 57 minutes Datametrex Receives $6M Purchase Order for Data Centre from Fortune 500 Conglomerate
Publié le 09/04/2026 à 13:30, il y a 1 heure 57 minutes ESGold Advances Toward Production and Exploration Drilling as Mill Buildout Progresses in Parallel
Publié le 09/04/2026 à 13:30, il y a 1 heure 57 minutes ROK Resources Announces 2026 Capital Budget and 2025 Year-End Reserves
Publié le 09/04/2026 à 15:11, il y a 15 minutes Dr Anne-Marie Großmann-Minkwitz nominated for the election to the Supervisory Board of Vonovia
Publié le 09/04/2026 à 14:43, il y a 44 minutes ADS-TEC Energy and Elanga bring ultra-fast charging to Penske dealership in Australia
Publié le 09/04/2026 à 14:26, il y a 1 heure 1 minute EQS-Adhoc: Heidelberg Pharma AG: Heidelberg Pharma Determines Recommended Dose for Phase II Trial with ADC Candidate HDP-101
